Quantcast

Latest Autoimmunity Stories

2014-02-24 08:05:42

IMIM (Hospital del Mar Medical Research Institute) This discovery clears the path to developing more efficient vaccines against meningitis and pneumonia, responsible for the death of millions of children every year Researchers have discovered the presence of a novel subtype of innate lymphoid cells in human spleen essential for the production of antibodies. This discovery, published in the prestigious journal Nature Immunology, clears the path to the identification of novel strategies...

2014-02-11 16:25:01

ORLANDO, Fla., Feb. 11, 2014 /PRNewswire/ -- TNI BioTech Inc., (OTCQB:TNIB) a biotechnology company pioneering the development of?innovative therapies for autoimmune diseases by combating these fatal diseases through the activation and modulation of the body's immune system, today announced that it received notification from the U.S. Securities and Exchange Commission ("SEC") that the SEC has completed its review of the Company's Form 10 registration statement, effectively clearing...

2014-02-05 08:29:22

Strategic Business Leader Brings Complementary Product Commercialization and Rare Disease Expertise SAN DIEGO, Feb. 5, 2014 /PRNewswire/ -- aTyr Pharma ("aTyr"), an innovative biotherapeutics enterprise, announced today that Frederic Chereau has joined aTyr as president and chief operating officer. Mr. Chereau has more than 20 years of experience in bringing new rare disease products to market and has held key leadership positions at Shire and Genzyme. Mr. Chereau's appointment will...

2014-02-04 16:29:30

Lupus Research Organizations Welcome Big-Science Push to Drive New Therapies for Lupus Patients NEW YORK, Feb. 4, 2014 /PRNewswire/ -- The Alliance for Lupus Research (ALR) and the Lupus Research Institute (LRI) are proud to join the National Institutes of Health (NIH) in the Accelerating Medicines Partnership (AMP) launched today to speed new paths to treatment for lupus and autoimmune diseases. The new $230 million collaboration will harness the collective knowledge and resources...

2014-02-04 12:27:31

Lupus Foundation of America Joins a Five-Year Initiative to Bring Together Government, Academia, Industry and Nonprofit Health Organizations to Harness Capabilities and Resources WASHINGTON, Feb. 4, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America will partner with the Foundation for the National Institutes of Health (FNIH) to support a new five-year initiative that will accelerate the ability to develop new medicines for lupus and other diverse and complex diseases....

2014-01-30 16:26:47

HAYWARD, Calif., Jan. 30, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, announced today that Paul F. Truex, President and Chief Executive Officer, will present a corporate update on the progress of the Company's development programs including additional plans for blisibimod beyond autoimmune disorders at three conferences in February and early March. Investor...

2014-01-14 16:25:08

Brings Total to $6.6 Million to Educate Healthcare Professionals on Front-Lines of Care NEW YORK, Jan. 14, 2014 /PRNewswire/ -- The 2014 Omnibus Appropriations Bill released by the U.S. Congress last night provides $2 million to further the Lupus Initiative, the lupus provider education program conceived by the Lupus Research Institute (LRI) in collaboration with the federal government. Expected to pass this week, the appropriation will bring total support to $6.6 million for the...

2014-01-13 12:27:53

SEATTLE, Jan. 13, 2014 /PRNewswire/ -- Adaptive Biotechnologies announced today a biomarker discovery agreement facilitated by the Johnson & Johnson Innovation Center in California. Under the agreement, Adaptive will use its patented immune profiling assay, immunoSEQ(TM), to enable an in-depth characterization of the immune response to diseases being studied and select immunology and oncology drugs being developed by Janssen Research & Development, LLC (Janssen). The...

2014-01-08 08:28:48

PORTLAND, Ore., Jan. 8, 2014 /PRNewswire-USNewswire/ -- To advance understanding of psoriasis--the most common autoimmune disease in the country, affecting up to 7.5 million Americans--and help scientists and clinicians improve treatments and patient outcomes, the National Psoriasis Foundation (NPF) and the Consortium of Rheumatology Researchers of North America, Inc. (CORRONA) will create the first psoriasis registry co-developed and co-administered by a nonprofit. (Photo:...

2014-01-07 23:01:17

A 2.5-Day Summit Providing Groundbreaking Approaches to Treating Patients With Interrelated Autoimmune Conditions Malvern, PA (PRWEB) January 07, 2014 The Interdisciplinary Autoimmune Summit (IAS) is pleased to announce the Keynote Address to be presented by Noel R. Rose, MD, PhD, Professor of Pathology, Professor of Molecular Microbiology and Immunology, Director, Johns Hopkins Center for Autoimmune Disease Research, The Johns Hopkins Medical Institutions. On Friday, June 20, 2014 at...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.